Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
Status:
Withdrawn
Trial end date:
2019-04-12
Target enrollment:
Participant gender:
Summary
The goal of this study will aim to determine if adding phenobarbital or ketamine to a
symptom-triggered benzodiazepine regimen decreases the rate of intensive care unit admissions
during the treatment of alcohol withdrawal syndrome when compared to symptom-triggered
benzodiazepine therapy alone.